Segall Bryant & Hamill’s Phibro Animal Health PAHC Stock Holding History
Bought
Maintained
Sold
Other funds holding PAHC
Segall Bryant & Hamill's PAHC Position: Q2 2026 in Review
Segall Bryant & Hamill reduced its Phibro Animal Health (PAHC) stake by 8.9% in Q2 2026, selling an estimated $390K and leaving 95,068 shares worth $2.99M. The position accounts for 0.04% of the portfolio, ranked #392.
Segall Bryant & Hamill first reported a position in PAHC in Q2 2018 and has held it in 18 quarters since. The position peaked at $21.7M in Q2 2018. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.
- Segall Bryant & Hamill held 95,068 shares of Phibro Animal Health worth $2.99M as of Q2 2026.
- Segall Bryant & Hamill sold 9,233 Phibro Animal Health shares in Q2 2026, an estimated $390K.
- Phibro Animal Health made up 0.04% of Segall Bryant & Hamill's portfolio in Q2 2026, its #392 holding.
- Segall Bryant & Hamill first reported a position in Phibro Animal Health in Q2 2018 and has held it in 18 quarters since.
- Segall Bryant & Hamill's Phibro Animal Health position peaked at $21.7M in Q2 2018.
- 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.
Based on Segall Bryant & Hamill's 13F filing for Q2 2026, filed 12 Aug 2026.